Behavioral science in diabetes. Contributions and opportunities
R E Glasgow1, E B Fisher, B J Anderson
1AMC Cancer Research Center, Denver, Colorado 80214, USA. glasgowr@amc.org
Diabetes Care
|May 20, 1999
Summary
Behavioral science research in diabetes shows promise for improving self-management and patient empowerment. Integrating these findings into practice requires changes from researchers and users to enhance diabetes care and quality of life.
Area of Science:
- Behavioral science
- Diabetes research
- Public health
Background:
- Behavioral science significantly impacts diabetes self-management and patient empowerment.
- Interventions target children, adolescents, and specific issues like blood glucose awareness and depression.
Purpose of the Study:
- To summarize current behavioral research and practice in diabetes.
- To identify future directions for behavioral science in diabetes care.
Main Methods:
- Review of behavioral science contributions to diabetes self-management, empowerment, pediatric interventions, and complication management.
- Identification of emerging areas: quality of life, worksite/community programs, technology interventions, and translation research.
- Analysis of the gap between research findings and clinical practice integration.
Main Results:
- Behavioral science offers promising avenues for improving diabetes care, including quality of life and management of complications.
- A significant gap exists between research advancements and their implementation in routine diabetes care.
- Key areas for future contributions include technology-based interventions and translation research in real-world settings.
Conclusions:
- Behavioral scientists and knowledge users (healthcare professionals, organizations, funders) must adapt to integrate behavioral science effectively.
- Integrating behavioral science with medical, technological, and policy advances can enhance diabetes understanding and patient outcomes.
- Improved integration promises better patient care, enhanced quality of life, and improved public health for individuals with diabetes.
Related Concept Videos
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:20Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:21Behavior Modification
Behavioral approaches have often been criticized for ignoring mental processes and focusing solely on observable behavior. However, these approaches provide an optimistic perspective for individuals seeking to change their behaviors. Rather than concentrating on intrinsic personality traits, behavioral approaches suggest that even longstanding habits can be modified by changing the reward contingencies that maintain them.
A real-world application of operant conditioning principles is applied...
A real-world application of operant conditioning principles is applied...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.